High-dose chemotherapy following autologous hematopoietic stem cell transplantation for multiple myeloma in the real world setting. Single-center experience

High-dose chemotherapy following autologous hematopoietic stem cell transplantation for multiple myeloma in the real world setting. Single-center experience

Aim. To assess the long-term results of high-dose chemotherapy following autologous hematopoietic stem cell transplantation (autoHSCT) for multiple myeloma (MM) in the real setting and influence of different factors on the results. Materials and methods. From 2006 till 2018 in Pirogovs Center wer...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Nikita E. Mochkin, Vladislav O. Sarzhevskiy, Julia N. Dubinina, Elena G. Smirnova, Denis A. Fedorenko, Anna E. Bannikova, Dina S. Kolesnikova, Vladimir S. Bogatyrev, Anastasia A. Samoylova, Nikolay M. Faddeev, Vladimir Ya. Melnichenko
Formato: article
Lenguaje:RU
Publicado: IP Habib O.N. 2020
Materias:
multiple myeloma
high-dose chemotherapy
autologous hematopoietic stem cell transplantation
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Acceso en línea:https://doaj.org/article/71812a52bfeb4a50a069644ca48f8b9e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/71812a52bfeb4a50a069644ca48f8b9e

Ejemplares similares